42 Hayarkon Street
Yavne 8122745
Israel
972 7 797 14100
https://www.mediwound.com
Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 77
Name | Title | Pay | Exercised | Year Born |
---|---|---|---|---|
Prof. Lior Rosenberg M.D. | Co-Founder & Medical Director | 398k | N/A | 1946 |
Mr. Boaz Gur-Lavie CPA, M.B.A. | Chief Financial Officer | 309k | N/A | 1974 |
Mr. Yaron Meyer Adv. | Exec. VP, Gen. Counsel & Corp. Sec. | 240k | N/A | 1979 |
Dr. Ety Klinger | Chief R&D Officer | 344k | N/A | 1962 |
Mr. Ofer Gonen B.Sc. | Chief Exec. Officer | N/A | N/A | 1973 |
Mr. Tzvi Palash B.Sc., M.Sc. | Chief Operating Officer | N/A | N/A | 1957 |
Mr. Stephen T. Wills CPA, CPA, MST | Exec. Director | N/A | N/A | 1957 |
Dr. Robert J. Snyder CWS, D.P.M., F.A.C.F.A.S., FFPM, M.B.A., M.Sc. | Chief Medical Officer | N/A | N/A | N/A |
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. The company also develops EscharEx, which has completed Phase II clinical trials for the debridement of chronic and other hard-to-heal wounds; MW005, which is in phase I/II for the treatment of low-risk basal cell carcinoma. MediWound Ltd. was founded in 2000 and is headquartered in Yavne, Israel.
MediWound Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.